National Health (Highly specialised drugs program for hospitals) Special Arrangement Amendment Instrument 2013 (No. 1) (No. PB 10 of 2013) (Cth)
PB 10 of 2013
National Health (Highly specialised drugs program for hospitals) Special Arrangement Amendment Instrument 2013 (No. 1)
National Health Act 1953
___________________________________________________________________________
I, KIM BESSELL, Assistant Secretary, Pharmaceutical Access Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this Amendment Instrument under subsections 100(1) and 100(2) of the National Health Act 1953.
Dated 15 February 2013
KIM BESSELL
Assistant Secretary
Pharmaceutical Access Branch
Pharmaceutical Benefits Division
Department of Health and Ageing
___________________________________________________________________________
1 Name of Instrument
(1)This Instrument is the National Health (Highly specialised drugs program for hospitals) Special Arrangement Amendment Instrument 2013 (No.1).
(2)This Instrument may also be cited as PB 10 of 2013.
2 Commencement
This Instrument commences on 1 March 2013.
3 Amendments to PB 116 of 2010
Schedule 1 amends the National Health (Highly specialised drugs program for hospitals) Special Arrangement 2010 (PB 116 of 2010).
Schedule 1 Amendments
Section 3
[1] Schedule 1, entry for Ibandronic acid in the column headed ‘Responsible Person’
Substitute:
RO
[2] Schedule 1, after entry for Nevirapine in the form Tablet 200mg with manner of administration Oral and brand Nevirapine Alphapharm
insert:
| Nevirapine RBX | RA | EMP | C3586 C3587 C3588 C3589 | 120 | 5 | D |
Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.
See
0
0
0